Eventide Asset Management, LLC Syndax Pharmaceuticals Inc Transaction History

Eventide Asset Management, LLC

$5.26 Billion
Q2 2025

A detailed history of Eventide Asset Management, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Eventide Asset Management, LLC holds 1,414,081 shares of SNDX stock, worth $18.3 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

1,414,081

Previous 1,178,062 20.03%

Holding current value

$18.3 Million

Previous $14.5 Million 8.49%

% of portfolio

0.25%

Previous 0.31%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.9 - $14.15 $2.1 Million - $3.34 Million	236,019 Added 20.03%	1,414,081 $13.2 Million
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $4.9 Million - $8.53 Million	391,072 Added 49.69%	1,178,062 $15.6 Million
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $14.1 Million - $19.5 Million	786,990 New	786,990 $15.1 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $15.9 Million - $22.7 Million	-1,165,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $6.42 Million - $9.16 Million	462,652 Added 65.87%	1,165,000 $22.3 Million
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $17.6 Million - $33.1 Million	-1,314,645 Reduced 65.18%	702,348 $12.1 Million
Q1 2021 May 14, 2021	BUY	$19.28 - $24.59 $1.37 Million - $1.75 Million	70,993 Added 3.65%	2,016,993 $45.1 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $18.8 Million - $33 Million	1,246,800 Added 178.32%	1,946,000 $43.3 Million
Q3 2020 Nov 13, 2020	BUY	$13.39 - $17.48 $2.77 Million - $3.61 Million	206,700 Added 41.97%	699,200 $10.3 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $2.38 Million - $5.58 Million	265,820 Added 117.27%	492,500 $7.3 Million
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $1.51 Million - $2.73 Million	226,680 New	226,680 $2.49 Million
Q4 2017 Feb 14, 2018	SELL	$7.8 - $12.94 $1.76 Million - $2.91 Million	-225,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $2.45 Million - $2.86 Million	225,000	225,000 $2.63 Million

Others Institutions Holding SNDX

# of Institutions

250

Shares Held

100M

Call Options Held

1.28M

Put Options Held

1.29M

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $734M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Account

Eventide Asset Management, LLC Syndax Pharmaceuticals Inc Transaction History